Scale Venture Partners Managing Director, Rob Theis, who invests in technology infrastructure and applications tells how it is a great time to invest in successful consumer applications that can be brought to the enterprise.
His latest investment, HubSpot is an example of such an investment. HubSpot has incorporated the products, processes and methodologies to make best of breed marketing applications for small and medium sized businesses.
Jennifer Jones Venture Perspectives by Scale Venture Partners HubSpot, Rob Theis, Scale Venture Partners, venture capital, Venture Perspectives
Andy Vitus discusses how he approaches investing in cloud computing. He describes how SVP talked to hundreds of directors in data centers so they could learn how to work more efficiently. As an investor in start ups, Andy shares SVP’s most cost-effective methods for growing a company today.
Jennifer Jones Venture Perspectives by Scale Venture Partners Andy Vitus, Cloud Computing, Scale Venture Partners, SVP
It’s August 2009 and in the last 12 months, Lou Bock’s portfolio has had some impressive success. He talks about how Zogenix, Horizon Therapeutics, Somaxon, Prestwick Pharmaceuticals and Orexigen have all done well. The Scale Venture Partners Managing Director has seen two positive Phase III outcomes, 2 FDA approvals and one progressing to approval since August 2008.
Jennifer Jones Venture Perspectives by Scale Venture Partners biopharmaceutical, emerging biopharmaceutical devices, FDA, Horizon Therapeutics, Lou Bock, Orexigen, Prestwick Pharmaceuticals, Scale Venture Partners, Somaxon, Zogenix
The last 12 months have been good for Scale Venture Partners‘ Managing Director Mark Brooks . As an investor in healthcare services, and medical devices, Mark delves into his successes, and speaks to his current investments and their bright future.
Jennifer Jones Venture Perspectives by Scale Venture Partners Healthcare, Healthcare Services, Mark Brooks, Medical Devices, Scale Venture Partner, SVP, Venture Perspectives
Capital efficiency and regulatory hurdles are the two main challenges for investing in healthcare today. Scale Venture Partners Managing Director, Lou Bock shares these insights as well as discussing what is most important to him in an investment today.
Jennifer Jones Corporate, Venture Perspectives by Scale Venture Partners capital efficiency, Healthcare, Jennifer Jones, Lou Bock, Scale Venture Partners, Venture Perspectives
Reflecting on his life in venture capital, Managing Director, Jim Jones shares his thoughts on the best areas for investment today. At Scale Venture Partners, he sees three key trends as most intriguing: the cost of data in the enterprise, energy efficiency, and the destruction of the personal computer. He speaks out candidly on these trends and what is most challenging about this environment.
Jennifer Jones Corporate, Venture Perspectives by Scale Venture Partners energy efficiency, Jennifer Jones, Jim Jones, Scale Venture Partners, Venture Capital Investing, Venture Perspectives
Scale Venture Partners Managing Director, Sharon Wienbar gives listeners her perspective on life of a venture capitalist and what her interests are in investing. She is most excited about crowdsourcing, vertical content and business software-as-a-service. Despite the current recessionary environment, Sharon’s outlook remains upbeat.
Jennifer Jones Corporate, Venture Perspectives by Scale Venture Partners crowdsourcing, Jennifer Jones, recession, SAAS, Scale Venture Partners, Sharon Wienbar, Software as a Service, venture capital, Venture Perspectives, vertical content
